Neuroone Medical Technologies Corp (NMTC)

Currency in USD
0.749
-0.011(-1.45%)
Closed·
After Hours
0.734-0.015(-1.99%)
·
NMTC Scorecard
Full Analysis
Analysts anticipate sales growth in the current year
Earnings results expected in 5 days
NMTC is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.7170.770
52 wk Range
0.3951.390
Key Statistics
Prev. Close
0.76
Open
0.77
Day's Range
0.717-0.77
52 wk Range
0.395-1.39
Volume
162.92K
Average Volume (3m)
217.85K
1-Year Change
1.07%
Book Value / Share
0.04
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
NMTC Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
1.450
Upside
+93.59%
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Neuroone Medical Technologies Corp Company Profile

NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for spinal cord stimulation, radio frequency and brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other pain-related neurological disorders. The company also focuses on applications of its technology associated with artificial intelligence. It has partnership with RBC Medical Innovations to develop a radio frequency ablation generator. NeuroOne Medical Technologies Corporation is based in Eden Prairie, Minnesota.

Neuroone Medical Technologies Corp Earnings Call Summary for Q2/2025

  • NeuroOne Medical (NMTC) beats Q1 2025 EPS expectations (-$0.07 vs -$0.09), but misses revenue ($1.4M vs $2.4M forecast)
  • Stock surges 6.62% in premarket despite revenue miss; product revenue up 97% in H1 fiscal 2025
  • Net loss reduced to $500,000 from $6.2M; product gross margins increase to 57.9%, more than doubling YoY
  • Company projects FY2025 product revenue of $8-10M, a 132-190% increase; expects to be fully funded through fiscal 2026
  • CEO highlights strong financial position with no debt; focus on strategic partnerships and product innovations for growth
Last Updated: 13/05/2025, 14:18
Read Full Transcript

Compare NMTC to Peers and Sector

Metrics to compare
NMTC
Peers
Sector
Relationship
P/E Ratio
−5.7x−4.2x−0.5x
PEG Ratio
−0.09−0.190.00
Price/Book
33.1x2.7x2.6x
Price / LTM Sales
6.5x2.8x3.3x
Upside (Analyst Target)
93.6%42.7%43.5%
Fair Value Upside
Unlock9.6%6.8%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 1.450
(+93.59% Upside)

Earnings

Latest Release
May 13, 2025
EPS / Forecast
-0.07 / -0.09
Revenue / Forecast
1.40M / 2.40M
EPS Revisions
Last 90 days

NMTC Income Statement

People Also Watch

247.45
AVAV
-4.68%
37.72
EXEL
+0.88%
8.7800
CYCC
-2.12%

FAQ

What Stock Exchange Does Neuroone Medical Trade On?

Neuroone Medical is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Neuroone Medical?

The stock symbol for Neuroone Medical is "NMTC."

What Is the Neuroone Medical Market Cap?

As of today, Neuroone Medical market cap is 37.29M.

What Is Neuroone Medical's Earnings Per Share (TTM)?

The Neuroone Medical EPS (TTM) is -0.22.

When Is the Next Neuroone Medical Earnings Date?

Neuroone Medical will release its next earnings report on 13 Aug 2025.

From a Technical Analysis Perspective, Is NMTC a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Neuroone Medical Stock Split?

Neuroone Medical has split 1 times.

How Many Employees Does Neuroone Medical Have?

Neuroone Medical has 17 employees.

What is the current trading status of Neuroone Medical (NMTC)?

As of 09 Aug 2025, Neuroone Medical (NMTC) is trading at a price of 0.75, with a previous close of 0.76. The stock has fluctuated within a day range of 0.72 to 0.77, while its 52-week range spans from 0.40 to 1.39.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.